GCISmith & Nephew H1 profits come in ahead of expectations
Medical equipment manufacturer said on Thursday that interim profits had come in ahead of market expectations, thanks in no small part to the company's 12-point turnaround plan.
Smith & Nephew said first-half revenues were up 4.3% at $2.8m, while operating profits rallied 19.5% to $328.0m and trading profits were almost 13% higher at $471.0m.
Cash generated from operations rose from $215.0m in H123 to $368.0m in H124 as S&N made marked improvements in trading cash flow conversion, rising to 60% from 26% at the same time a year earlier.
The FTSE 100-listed group credited much of its improved performance to its 12-point plan, which includes winning market share and fixing its orthopaedics division, as well as regaining momentum across its robotics, trauma, and knee and hip implant units.
Chief executive Deepak Nath said: "Today's results are further evidence of the good progress we are making transforming Smith & Nephew into a higher growth and more profitable business.
"The methods we employed in achieving these successes give me confidence that we will also turn around US hip and knee Implants and we expect to see a step up through the second half of the year."
As of 0900 BST, S&N shares were up 7.48% at 1,207.0p.
Reporting by Iain Gilbert at Sharecast.com
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.